Complex interaction of the pathologies of Alzheimer’s disease (amyloid-β plaques and tau-containing neurofibrillary tangles) and Lewy body disease (α-synuclein) are enthusiastically discussed in recent studies [24, 25]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.